Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1998-01-23
1999-08-10
Saunders, David
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
424810, 514 2, 514 3, 514 4, 514 21, 514826, 514866, 514885, 514903, 514253, A61K 3900, A61K 3817, A61K 3828, A61K 3800
Patent
active
059355778
ABSTRACT:
A combination of a mucosally administrable bystander antigen and an orally, enterally, or parenterally administrable methotrexate is employed to make a pharmaceutical formulation and to treat or prevent autoimmune disease. The amounts of bystander antigen and methotrexate are effective in combination to suppress autoimmune response associated with the autoimmune disease
REFERENCES:
patent: 5399347 (1995-03-01), Trentham et al.
patent: 5571499 (1996-11-01), Hafler et al.
patent: 5571500 (1996-11-01), Hafler et al.
patent: 5641474 (1997-06-01), Hafler et al.
patent: 5645820 (1997-07-01), Hafler et al.
patent: 5720955 (1998-02-01), Weiner et al.
patent: 5783188 (1998-07-01), Weiner et al.
patent: 5843445 (1998-12-01), Weiner et al.
patent: 5856446 (1999-01-01), Weiner et al.
Trentham, D.E. et al. Science 261:1727-1730, Sep. 1993.
Barnett, M.L. et al. Arthritis & Rheumatism 39(4):623-628, Apr. 1996.
Al-Sabbagh Ahmad
Nelson Patricia A.
Weiner Howard L.
Autoimmune Inc.
Saunders David
VanderVegt F. Pierre
LandOfFree
Treatment of autoimmune disease using tolerization in combinatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of autoimmune disease using tolerization in combinatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of autoimmune disease using tolerization in combinatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117583